Group Tx-vac-flu (n=18) Tx-no vac-flu (n=6) Healthy-flu (n=12) Tx-vac-no flu (n=13) Number of patients treated with oseltamivir (%) 17 (94%) 6 (100%) 4 (33%)* N/A Duration of treatment with oseltamivir (days) {median IQR]} 5 [5-7] 7.5 [5-10] 5 [5] Tx-vac-flu=Transplant recipients who developed influenza despite influenza vaccination Tx-no vac-flu=Transplant recipients who developed influenza in the absence of influenza vaccination Healthy-flu=Healthy people who developed influenza Tx-vac-no flu=Transplant recipients who received influenza vaccination and did not develop influenza N/A=not applicable. IQR=interquartile range *P=0.0006 compared to the tx-vac-flu group P=not significant for all other comparisons to the tx-vac-flu group in this table.

Table 5: Treatment.